This scholarly profile was discovered from public research metadata and has not yet been claimed. Is this your research profile?
Robert A. Kyle
UnverifiedResearcher · US
Publications
10
Citations
24105
max across sources
Profile views
5
bot-filtered
Verification
L0
Overview
AI-generatedRobert A. Kyle (RTX-00000097) based in US is a researcher on ResearchTrics. Lists research interests: amyloidosis: diagnosis, treatment, outcomes, cancer treatment and pharmacology, chronic lymphocytic leukemia research, multiple myeloma research and treatments, protein degradation and inhibitors. Has 10 publications recorded, including "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma" (2016), "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma" (2014), "Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients" (2013).
An AI overview generated from this profile’s verified records — an interpretation, not a verified statement.
Research interests
- amyloidosis: diagnosis, treatment, outcomes
- cancer treatment and pharmacology
- chronic lymphocytic leukemia research
- multiple myeloma research and treatments
- protein degradation and inhibitors
Publications (20)
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma3110 cites
The Lancet Oncology · 2016 · DOI
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma3110 cites
The Lancet Oncology · 2016 · DOI
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma5047 cites
The Lancet Oncology · 2014 · DOI
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma5047 cites
The Lancet Oncology · 2014 · DOI
- 2266 cites
- 2266 cites
- International uniform response criteria for multiple myeloma2662 cites
Leukemia · 2006 · DOI
- International uniform response criteria for multiple myeloma2662 cites
Leukemia · 2006 · DOI
- Prevalence of Monoclonal Gammopathy of Undetermined Significance1434 cites
New England Journal of Medicine · 2006 · DOI
- Prevalence of Monoclonal Gammopathy of Undetermined Significance1434 cites
New England Journal of Medicine · 2006 · DOI
- International Staging System for Multiple Myeloma2953 cites
Journal of Clinical Oncology · 2005 · DOI
- International Staging System for Multiple Myeloma2953 cites
Journal of Clinical Oncology · 2005 · DOI
- Multiple Myeloma1292 cites
New England Journal of Medicine · 2004 · DOI
- Multiple Myeloma1292 cites
New England Journal of Medicine · 2004 · DOI
- Review of 1027 Patients With Newly Diagnosed Multiple Myeloma2454 cites
Mayo Clinic Proceedings · 2003 · DOI
- Review of 1027 Patients With Newly Diagnosed Multiple Myeloma2454 cites
Mayo Clinic Proceedings · 2003 · DOI
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance1484 cites
New England Journal of Medicine · 2002 · DOI
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance1484 cites
New England Journal of Medicine · 2002 · DOI
